Lachelle D. Weeks
Oncology
450 Brookline Ave
Boston, MA 02215
Boston, MA 02215
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
The hematology workforce in the United States: past, present, and strategies for the future.
Journal: Blood advances
Published: April 06, 2026
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI).
Journal: Arthritis care & research
Published: March 05, 2026
Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.
Journal: Seminars in hematology
Published: February 06, 2026
Clinical Impact and Dynamics of Clonal Hematopoiesis with 177Lu-PSMA-617 Therapy in Advanced Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 20, 2026
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: December 15, 2025
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: December 15, 2025
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome.
Journal: Journal of clinical medicine
Published: November 16, 2025
Clinical strategies for leukemia management: Recommendations from the Bridging the Gaps in Hematology Oncology Consensus Conference 2025.
Journal: Leukemia research
Published: September 16, 2025
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.
Journal: Leukemia
Published: September 02, 2025
Establishing a consensus definition of VEXAS flare for clinical research.
Journal: Rheumatology (Oxford, England)
Published: July 31, 2025
Last Updated: 09/26/2026